Cisplatin, gemcitabine, and ifosfamide as weekly therapy: A feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma

Lance C. Pagliaro, Randall E. Millikan, Shi Ming Tu, Dallas Williams, Danai Daliani, Christos N. Papandreou, Christopher J. Logothetis

Research output: Contribution to journal › Article › peer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Cisplatin, gemcitabine, and ifosfamide as weekly therapy: A feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences